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The control of hepatic 6-ph~phofructo-2-kin~/  
fructose 2,6-bisphosphatase gene expression by glu- 
cagon was studied.  Intraperitoneal  administration of 
glucagon  rapidly  decreased  the  fructose 2,6-bisphos- 
phate  content by phosphorylation of 6-phosphofructo- 
2-kinaselfructose  2,6-bisphosphatase  and  diminution 
of its V-. Immunologic studies using a specific liver 
antibody  showed  that  the  amount  of  enzyme  rapidly 
decreased.  Northern  blot analysis showed  that  the iso- 
zyme  expressed is the  adult liver form.  The  6-phospho- 
fructo-2-kinase/fructose 2,6-bisphosphatase mRNA 
content  decreased,  whereas  that of phosphoenolpyru- 
vate carboxykinase  increased,  and  that  of  albumin  did 
not  change.  Run-on  transcription assays with isolated 
nuclei  showed i ~ i b i t i o n  in the relative transcription 
rate of  the 6-phosphofructo-2-kinaselfructo~ 2,6-bis- 
phosphatase gene and a stimulation of phosphoenol- 
pyruvate  carboxykinase  gene.  The  regulation  of 
mRNA stability of 6-phosphofructo-2-kinase/fructose 
2,6-bisphosphatase  by  glucagon was also  studied.  The 
haif-life of mRNA decreased in the  presence  of  gluca- 
gon, suggesting that  proteins  modulated  by a gfucagon- 
dependent  process are regulating its stability. The  time 
course  of mRNA levels correlated with the  transcrip- 
tion  inhibition  of  gene  and  destabilization  of mRNA, 
indicating  that  glucagon  modulates  6-phosphofructo- 
2-kinaselfructose 2,6-bisphosphatase gene expression 
at both transcriptional  and  posttranscriptional levels. 
Rat liver 6-phosphofructo-2-kinase/€ructose 2,6-bisphos- 
phatase (PFK-S/FBPase-2; EC 2.7.1.105/3.1.3.46)’ is encoded 
by a gene  whose expression is subject to a complex pattern of 
hormonal regulation (1). The  bi~nctional enzyme PFK-2/ 
FBPase-2 catalyzes both the synthesis and degradation of 
Fru-2,6-P~, stimulator of 6-phosphofructo-1-kinase and inhib- 
itor of fructose 1,6-bisphosphatase. Since these enzymes cat- 
alyze  reciprocal reactions in  the fructose 6-phosphate/fructose 
1,6-bisphosphate substrate cycle, the level of Fru-2,6-Pz mod- 
ulates the carbon flow through the coupled  metabolic path- 
ways of glycolysis and g~uconeogenesis in m ~ m ~ i a n  liver. 
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PF~-2 /F~Pase -2  activities are regulated by substrates  and 
effectors and by phospho~lation/dephosphory~ation by 
CAMP-dependent protein kinase (1-3).  Glucagon, acting via 
CAMP-dependent protein kinase, causes the phosphorylation 
of hepatic PFK-2lFBPase-2. The phosphorylation results in 
the activation of FBPase-2 and  in  the inactivation of PFK-2, 
producing the disappearance of Fru-2,6-P2 from the liver  cell 
(1-3). A similar situation has been found during starvation 
(1-41, diabetes (149, and  after  partial hepatectomy (6), Fru- 
2,6-P2 being a good marker of hepatocyte metabolic state. In 
these situations, the gene expression of PFK-Z/FBPase-2 is 
also modulated. The amount of the bifunctional enzyme  de- 
creased (6-81, whereas its mRNA levels were not modified 
during starvation (7) or decreased  in diabetes (8) and after 
partial hepatectomy (9). The Fru-2,6-P2 content, the  amount 
of enzyme, and its mRNA were restored or increased by 
refeeding a high carbohydrate diet (7), by insulin administra- 
tion (7,8),  or through the regenerative process (6,9), respec- 
tively. It seems  obvious that in all these situations glucagon 
has an important role in  the enzyme  regulation.  However, the 
mechanisms by  which the glucagon affects the expression of 
PFK-2/FBPase-2 gene have been only partially studied. In 
rat hepatoma cells (10) and in primary culture of hepatocytes 
( l l ) ,  dibutyril CAMP prevented the increase in PFK-2/ 
FBPase-2 mRNA induced by insulin or  glucocorticoids. 
In order to study the effects of glucagon  on the regulation 
of gene expression of PFK-2FBPase-2, we have injected 
glucagon into rats intraperitoneally and analyzed its effects 
on the activity, amount of enzyme, mRNA  levels, transcrip- 
tion rate, and mRNA stability of PFK-2IFBPase-2. We report 
here that glucagon modulates the PFK-2FBPase-2 gene 
expression at both transcriptional and posttranscriptional 
levels. 
EXPERI~ENTAL PROCEDURES 
MaterMls-[n-3zP]dCTP (3000 Ci/mmol), [n-”P]UTP (3000 Ci/ 
mmol), [5,6-3H]uridine (35-50 Ci/mmol) were from Amersham Corp. 
The random primed DNA labeling kit  and restriction endonucleases 
were from Boehringer Mannheim. N-bybond membranes were from 
Amersham. Fetal calf serum and cell culture media were from Life 
Technologies, Inc. Enzymes and other biochemical reagents were 
either from Boehringer Mannheim or Sigma. All chemicals were  of 
analytical grade. Rapid glucagon and long acting glucagon (zinc- 
protamine-glucagon; kindly supplied by Dr. Axel Kahn, Institut de la 
SantL. et de la Recherche ML.dicale, Paris) were from Novo Ind. 
Animals-Fed male Sprague-Dawley rats (180-220 g) were sub- 
jected to a 12-h light/l2-h dark cycle (light periods starting  at 0800 
h). Rats were injected at 8 a.m. intraperitoneally with both rapid 
glucagon (1 mg/kg) and with long acting glucagon (zinc-protamine- 
glucagon, 5.4 mgfkg) in order to obtain a rapid and sustained hor- 
monal impregnation (12). Control rats were injected with 0.15 M NaCl 
solution. The animals were killed by decapitation. Liver was  removed 
and quickly freeze-clamped and placed into liquid nitrogen. 
Metabolite and Enzyme Assays-Fru-2,6-Pz was extracted and 
measured as described by Van Schaftingen et al. (13). PFK-2 activity 
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was measured at  pH 8.5 ( Vmm) and at pH 6.5, as described by Bartrons 
et ai. (14), after  partial purification of the extract with polyethylene 
glycol 6000 (6-21%). The PFK-2 activity ratio  (pH 6.5/pH 8.5) is a 
measure of the phosphorylation state of the bifunctional enzyme (14). 
The protein concentration was determined according to Bradford 
(15), using bovine serum albumin as standard. 
Western Bbt A ~ ~ y s ~ - I m m u n o b l o t  analysis was performed essen- 
tially as described by Burnette (16) with a 1:200 dilution of polyclonal 
antibody raised against a synthetic decapeptide (GELTQTRLQK), 
co~esponding  to  the N terminus of rat liver PFK-2FBPase-2 (17). 
This liver-specific antibody was a gift from Louis Hue (Louvain 
University, Belgium). Bound antibodies were detected by incubation 
with 1261-labeled Protein A (1-2 X 10' cpmfml) for 30 min, and, after 
washing, the film was exposed to x-ray film. The amount of enzyme 
was evaluated by dens~tometric scanning of the a u t o r ~ ~ o ~ ~ s  using 
an LKB Ultroscan XL laser densitometer and GelScan XL (2.1) 
software. 
RNA Iso~t ion and N ~ r ~ ~ r n  Bbt  A alysis"l'ota1 RNA was ex- 
tracted from  frozen rat tissues by the LiCl/urea method (18). North- 
ern blot analysis was carried  out using standard procedures (19). The 
following probes were used a 1.4-kb EcoRI fragment isolated from 
the cDNA for PFK-2/FBPase-2, common probe (7); a 0.3-kb EcoRX/ 
BanlI fragment isolated from the first exon for P ~ K - 2 ~ P a s e - 2 ,  
liver-specific probe (9); a 2.6-kb PstI fragment from cDNA clone 
(pPCKlO) for PEPCK (20); and a 1.1-kb PstI fragment isolated from 
cDNA clone fpRSA 13) for albumin (21). All DNA probes were 
generated by labeling with [ w ~ * P ] ~ C T P  to a specific radioactivity of 
~ 1 . 5  X 10' cpm/pg of DNA by random priming with Klenow  DNA 
poiymerase. The mRNA levels were evaluated by densitometric scan- 
ning of the a u t o r a ~ o ~ a m s .  
I s o ~ t i o n  of Liver Nuclei and Run-on ~ r a ~ c r i p ~ ~ o n  Analysis- 
Nuclei were isolated from liver by a modification of the method of 
Laitinen et al. (22). Fresh livers were homogenized with a Potter- 
Elvehjem kflon-glass homogenizer in 10 volumes of STM buffer (250 
mM sucrose, 50 mM Tris-HC1, pH 7.4, 5 mM MgSO,) containing 0.1 
mM phenylmethylsulfonyl fluoride and 0.5 pg/ml aprotinin, filtered 
though four layers of cheesecloth, and centrifuged at 800 X g for 10 
min at 4 "C. The pellet was resuspended in the same buffer and 
sedimented again at 800 X g for 5 min at 4 "C. The pellet was 
resuspended in RSB buffer (10 mM Tris-HCI, pH 7.4,lO mM NaCI, 
3 mM MgC12) containing 0.1 mM phenylmethylsulfonyl fluoride and 
0.5 pg/ml aprotinin, and  the cells were  lysed  by stepwise addition of 
10% Nonidet P-40 to a final concentration of 0.5% with gentle 
vortexing (=30 9). Detergent extraction was repeated twice. Nuclei 
were then centrifuged at 800 X g for 5 min at 4 "C and washed three 
times with RSB buffer without detergent. The final pellet was resus- 
pended in nuclei storage buffer (40 mM Tris-HCl, pH 8.0, 10 mM 
MgC12,O.l  mM EDTA, and 40% glycerol) and stored at -80 "C. Intact 
nuclei without cytoplasmic remnants, as revealed by phase-contrast 
microscopy,  were thus obtained. The  entire isolation procedure was 
completed in 40  min. 
The run-on transcription reaction in isolated nuclei was carried 
out  at 30 "C for 20 min using the reaction mixture described (23). 
Twenty miflion nuclei were used per assay in a total reaction volume 
of 0.2 ml containing 200 pCi of [~U-~*P]UTP (specific activity 3000 
Ci/mmol). Labeled RNA was extracted from the reaction mixture 
and resuspended in prehybridization solution essentially as described 
previously (24). Labeled RNA products were hybridized to nylon 
membrane containing the liver-specific genomic  1.6-kb EcoRI/XbaI 
fragment for PFK-Z/FBPase-2 (10). The PEPCK DNA was the 
pPCK-B7.0 genomic cione {kindly suppfied by Dr. Richard W. Han- 
son, Case Western Reserve University, Ohio) (20). pBS vector was 
used as control for background hybridization. Prior  to hybridization, 
DNAs (4 pg/lane) hybridized to nylon membrane were incubated for 
6 h at 42 "C in  the prehybridization solution. The same amount  of 
radioactivity was added to each hybridization. The filters were washed 
as described (25). Autoradiography and densitometer scanning were 
carried out as with Northern blots. 
I s o ~ ~ ~ o n  and ~ ~ ~ a ~ ~ n  of ~ e ~ ~ ~ t e s - ~ e p a t o c y t e s  were pre- 
pared from male rats (14). Isolated hepatocytes (4 x lo6 cells/vial in 
a final volume of 2 ml) were preincubated with shaking for 30 min at 
37 "G in Krebs-Henseleit bicarbonate buffer, which  was ~ui l ibrated 
with Oz/COz (192)  at  pH 7.4 and contained 10 mM glucose and 1% 
bovine serum albumin. Actinomycin D (5  pg/ml) was added after  the 
preincubation. Glucagon M) was added where indicated. At the 
appropriate times, samples of the cell suspension were  removed and 
centrifuged at 350 X g €or 5 rnin at 4 "C, The  supernatants were 
discarded and  the pellets frozen in liquid nitrogen. RNA extraction 
and Northern blot analysis were carried out as described above. The 
viability of hepatocytes was monitored by trypan-blue exclusion, and 
was always greater than 90%. 
PulseChase Andysis-Isolated hepatocytes were plated with Wil- 
liams' E medium supplemented with fetal calf serum (5%, v/v?, 
glutamine (I mM), gentamycin (50 pg/ml), insulin (1 nM?, and dexa- 
methasone (1 nM) at a plating density of -6 million cells/piate (5 
milplate). After 3 h, the plating medium and unattached cells were 
removed and  the cells incubated with fresh medium and dexametha- 
sone (I p ~ )  for 16 h. After this time, the cells were  exposed for 3 h 
to [5,6-3H]uridine (0.15 mCi/plate, 1 pM final concentration) to label 
cellular RNA. To determine radioactive labeling, the cells were rinsed 
twice with medium and incubated with fresh medium containing 5 
mM unlabeled uridine and cytidine and in the absence or presence of 
glucagon M), cycloheximide (10 pg/ml), and cycloheximide- 
glucagon (10 pg/ml and M), respectively. At the indicated times, 
the medium  was decanted, and  the cells were  lysed directly with a 
solution containing 6 M urea and 3 M LiCl (18) and  the total RNA 
extracted  as described above. Labeled RNA ( lo6 cpm for 100 pg in 1 
ml) were hybridized to N-hybond (Amersham) membranes carrying 
slot  spots of linearized PFK-2/FBPase-2 cDNA (4 pg/lane). Linear- 
ized pBS plasmid DNA (4 pg/lane) was used as negative controf for 
nons~ecific hybridization. ~ybridization was carried out for 72 h. 
The membranes were  washed at room temperature with 0.1 X SSC 
(20 X SSC is 3 M NaCl and 0.3 M trisodium citrate at pH 7.4) and 
0.1% SDS for 5 min; 20 min at 50 "C with 0.1 X SSC and 0.1% S D S  
20 min a t  37 "C with 0.1 X SSC and RNase A (10 pg/ml); 20 min at 
50 "C with 0.1 X SSC and 0.1% SDS. Slots were  excised and then 
counted with 10 mi  of F-1 Normascint mixture (Scharlau, Spain) in 
a liquid scinti~lat~on counter (LS 5 0 0 0 ~ E  Beckman Instruments, 
Scotland). 
RESULTS 
Effect of Glucagon Administration on Fru-SG-P, Levels a d  
on the Amount and Activity of PFK-2/FBPuse-2 
Rats were injected intraperitoneally with both rapid and 
long acting glucagon in order to obtain a rapid and sustained 
hormonal impre~at ion  (1'2). In this situation, the Fru-2,6-Pz 
levels decreased rapidly (from 8.7 nmol/g to 1.4 nmollg at 5 
min) in parallel to  the phosphorylation and inactivation of 
bifunctional enzyme by CAMP-dependent protein kinase. The 
PFK-2 activity (V,,), and  its activity ratio decreased at 5 
min and remained low during the studied time (Fig. 1). One 
could argue that the differences found were due to stress by 
animal manipulation and/or to differences by circardian cycle. 
To rule out  this possibility, we analyzed the Fru-2,6-P2 levels, 
PFK-2 activity, and  its activity ratio from animals injected 
with a NaU physiological solution. Neither the Fru-2,6-P2 
levels, nor the PFK-2 activity were modified (Fig. I). To 
determine whether the amount of bi~nctional enzyme 
changed after glucagon a~in is t ra t ion ,  we used immunoblot- 
ting with a specific antibody raised against an N-terminal 
decapeptide specific to liver isozyme (17). We observed a 
decrease in  the protein level at 5-10 min, the content remain- 
ing low after  this time. Since the specific antibody equally 
recognized the  nonphospho~lated  and  the phosphorylated 
forms of the enzyme  (see  Ref. 9 and resufts not shown), the 
decrease in immunoreaction cannot be due to  the phosphoryl- 
ation of the enzyme  by  CAMP-dependent protein kinase (Fig. 
2) .  
Effect of ~ l ~ ~ o n  on the Expression of ~ F ~ - ~ / ~ ~ P ~ e - ~  
~~~A 
The relative abundance of PFK-2FBPase-2 mRNA was 
determined by Northern blot hybridization of total RNA 
extracted from livers at  various times following glucagon 
administration. We used a 1.4-kb cDNA probe (7) that rec- 
ognized the mRNAs of the different isozymes of PFK-2,' 
FBPase-2 (25), A decrease in PFK-2/FBPase-Z mRNA was 
observed after the  first minutes, with a minimum at 120  min, 
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FIG. 1. Fru-2,6-P2 content and PFK-2 activity. Fru-2,6-P2 
content, PFK-2 activity ratio, and PFK-2 activity from glucagon 
treated animals (0) or 0.15 M NaCl saline solution (0) are shown. 
Each  point shows the mean for three  to five rats. 
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FIG. 2. Amount of PFK-2FBPase-2 after glucagon admin- 
istration. Enzyme protein was measured after fractionation with 
polyethylene glycol 6000 (6-21%). Thirty pg of protein was used/lane 
for 10% SDS-polyacrylamide gel electrophoresis and  then transferred 
to nylon membranes and incubated with anti-PFK-Z/FBPase-2 liver- 
specific antibody. The intensity of the autoradiographic signal was 
quantified by laser densitometry and presented  as  a percentage of the 
signal obtained at  time zero, which was considered as 100%. A 
representative experiment is shown. The experiment was repeated 
three times with similar results. 
which was maintained after 240 min (Fig. 3). As control of 
this experiment, we analyzed the content of PEPCK and 
albumin mRNAs, since an increase of PEPCK mRNA content 
had previously been reported in  the presence of high levels of 
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FIG. 3. Time course of mRNA accumulation in glucagon- 
treated animals. Total RNA (20 pgllane)  extracted from normal (0 
h)  and glucagon-treated rat livers a t  different times were transferred 
to nylon membranes after electrophoresis in 1% agarose. The integrity 
of the RNA and  the equivalence of inputs were verified by observing 
the rRNA bands in the ethidium bromide-stained gels under UV 
irradiation. The blots were hybridized serially to four different probes 
as follows: PFK-2/FBPase-2 (common (0) and liver-specific (O)), 
PEPCK, and albumin cDNAs, as described under "Experimental 
Procedures." After each hybridization, the probe was eluated by 
washing the blot in 0.1 X SSC at  90-100 "C for 30 min. The intensity 
of the autoradiographic signal was quantified by laser densitometry 
and presented  as  a percentage of the signal obtained at  time zero, 
which was considered as 100%. Data  are means f S.E. from three  to 
four different animals. Representative  Northern blots are shown. 
glucagon or CAMP (1, 26-29), whereas the albumin mRNA 
levels were unmodified (9, 30). As control of the  stress by 
animal manipulation and/or differences by circardian cycle, 
we analyzed PFK-SIFBPase-2 mRNA content from animals 
injected with 0.15 M NaCl  solution, not observing variations 
in  the mRNA content during the  times analyzed (results  not 
shown). 
Since the 1.4-kb probe hybridizes with mRNAs of different 
isozymes (25), we measured the content of liver-specific 
mRNA by using  a specific 0.3-kb cDNA probe (9). This probe 
contains  the  entire coding region of the first exon of liver- 
specific transcript, including the nucleotides that encode the 
decapeptide corresponding to  the N terminus of liver PFK-2/ 
FBPase-2. The  pattern of expression was similar to  that found 
with the 1.4-kb probe (Fig. 3), suggesting that  the isozyme 
expressed is the  adult liver form. 
Transcriptional  Activity of the PFK-2/FBPase-2 Gene after 
Glucagon Administration 
To determine  whether the change in  the levels of PFK-2/ 
FBPase-2  mRNA after glucagon administration was due to a 
variation in  the  transcription  rate of the  PFK-2IFBPase-2 
gene, we performed a  series of nuclear run-on assays. Table I 
shows that the transcription rate of the rat liver PFK-2/ 
FBPase-2 gene decreased after glucagon administration in 
parallel to the decrease of mRNA (Fig. 3). The inhibitory 
effect of glucagon on PFK-2FBPase-2 gene transcription was 
rapid ( ~ 7 1 %  of inhibition a t  10 min), recovering at  240 min. 
As control of this experiment, we measured the  transcription 
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TABLE I 
T r a ~ c r ~ p t i o ~ ~  actiuity of tfbe F F K - ~ / F E F ~ e - Z  and PEPCK genes 
after glucagon administration 
Nuclear run-on assays were  performed  on  equal numbers of nuclei 
(2 X 10’) isolated from the rat liver at the indicated times after 
glucagon administration. Since the incorporation of counts varied 
with each nuclear preparation, hybridization was carried out with 
equal  numbers of counts per  each set. In vitro  extended  32P-labeled 
RNA transcripts were  hybridized to 4 - ~ g  samples of the indicated 
cDNAs  immobilized on  nylon  membranes.  Hybridization  was carried 
out as it is described under “Experimental Procedures.” Autoradi- 
ographs  were quantified by laser  densitometry and are  expressed  as 
arbitrary units after subtraction of the values obtained for vector 
DNA. Percent  values  were  calculated by assigning a value of  100 to 
the rate at t = 0. Data are means rfr S.E. from three rats. 
Time 
min units % units % 
Relative rate of gene  transcription 
PFK-2FBPaae-2 PEPCK 
0 1.7 +. 0.1 100  3.1 t 0.6 100 
5 0.8 +- 0.2 47 6.9 t 0.9 225 
10  0.5 rfr 0.1 29  5.4 rfr 0.1 174 
15  0.2 +. 0.1 12 9.4 t 0.2 303 
120 0.8 k 0.2 47 6.3 t 0.4  203 
240 1.5 rfr 0.1 88 4.5 t 0.3  145 
rate of PEPCK gene, since its  induction by cAMP  had  been 
reported (27-29, 31). As can be  seen  on  Table 1, a n  increase 
of the transcription  rate  was  observed after glucagon admin- 
istration,  and  this  remained  high  during  the  period  studied. 
Regulation of PFK-21FBPase-2 mRNA Half-life by Glucagon 
Effect of Cycloheximide-The glucagon regulation of PFK- 
Z/FBPase-P mRNA  content at the  transcriptional level does 
not  preclude  regulation at other  pretranslational levels. For 
example,  cAMP  regulates  both  the  rate of transcription of 
PEPCK and  the  stability of its mRNA (27-29, 31, 32). The  
possible  role of glucagon in  controlling the degradation  rate 
of PFK-2IFBPase-2 mRNA was estimated from the decay 
rate of the  mRNA  in  hepatocytes  incubated  in  media  contain- 
ing  actinomycin D (5 pg/ml) and  in  the  presence  or  absence 
of glucagon M). As seen in Fig. 4A, the half-life of PFK- 
2IFBPase-2  mRNA  was ~ 2 . 5  h, agreeing  with data previously 
reported (9-11). The presence of glucagon increased  the  half- 
life of mRNA (Fig. 4%). As a control, we analyzed  the  expres- 
sion of PEPCK, known to be stabilized by glucagon (32). As 
shown in Fig. 4B, the PEPCK mRNA levels were stabilized 
in  the  presence of glucagon. The  rapid  decrease of the PFK- 
21FBPase-2  mRNA content after glucagon administration in 
uiuo (Fig. 3) does not correlate with  the half-life of PFK-21 
FBPase-2 mRNA obtained  with  rat  hepatocytes  in  the pres- 
ence of glucagon  (Fig. 4A), suggesting that the  half-life ob- 
tained in these conditions does not reflect the half-life of 
PFK-21FBPase-2 mRNA in uiuo. One could argue, as de- 
scribed by other  mRNAs (33-351, that  actinomycin D could 
be affecting PFK-2FBPase-2 mRNA half-life. To answer 
this  question we have used pulse-chase protocols to directly 
assess PFK-21FBPase-2 mRNA half-life in hepatocytes in 
the  presence  or  absence of glucagon M). As shown  in 
Fig. 5, glucagon decreased the half-life of PFK-2IFBPase-2 
mRNA  from ~ 2 . 5  h to x15 min,  correlating  this  decrease  with 
the low content of mRNA  found after glucagon administration 
(Fig. 3). 
The  stability of certain  mRNAs is known to be affected  by 
translation (35). Cycloheximide, an  inhibitor of translation, 
causes stabilization of some mRNAs. This effect has been 
attributed to rapid loss of an  unstable  protein involved in  the 
cleavage of these  mRNAs (36). With  this possibility in  mind, 
we analyzed the half-life  of  PFK-Z/FBPase-2  mRNA  in  the 
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FIG. 4. Effects of glucagon in  the  decay  of PFK-a/FBPase- 
2 and PEPCK mRNAs in isolated hepatocytes. Hepatocytes 
were  isolated  from rat liver  and  incubated at 37 “C as described  under 
“Experimental  Procedures.”  All  cells were incubated  in the presence 
of  actinomycin D (5 pg/mt)  for the times  indicated. 0, hepatocytes 
were incubated  with  glucagon (lo-? M). At the times  indicated, the 
total RNA  was extracted  and transferred to nylon  membranes after 
eiectrophoresis  in 1% agarose  and  hybridized  with  PFK-Z/FBPase-2 
(common probe) (A) and PEPCK ( B )  cDNAs, as described under 
“Experimental Procedures.” The mRNA levels were quantified by 
laser  densitometry of autoradiograms and expressed  relative to the 
amount present at time zero, which was taken as 100%. Data are 
means  from three to four  different  animals. 
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FIG. 5. Effects of glucagon, cycloheximide, and cyelohexi- 
mide-glucagon on PFK-ZiFBPase-2 mRNA stability as meas- 
ured  by pulse-chase. Hepatocytes were incubated  for 3 h with  [5,6- 
3H]uridine (30 pCi/mi).  After  extensive  rinsing,  cells were incubated 
with  fresh  medium  containing 5 mM unlabeled  uridine  and  cytidine 
in the absence (0 ,O)  or  presence (El, m) of  10  pg/ml  cycloheximide 
and in the absence (0,O) or  presence (0, m) of lo-’ M glucagon  for 
the indicated  times.  Labeled total RNA was then isolated.  Incorpo- 
ration of labeled nucl~tides at t = 0 was 11,700 cpmfpg RNA, 
maintaining constant during the time  studied and in the different 
conditions.  Labeled  RNA  was  hybridized to N-hybond membranes 
carrying slot spots of linearized PFK-2/FBPase-2 and pBS  plasmid 
DNAs. The selection of mRNA is indicated under “Experimental 
Procedures.” The amount of radioactivity hybridizing to PFK-2/ 
FBPase-2 at t = 0 was 1.6 cpm/rg RNA, and the nonspecific  hybrid- 
ization  with  pBS  plasmid  was 0.3 cpm/pg RNA, the difference  being 
(1.3 cpmlpg RNA) the specific for PFK-2~BPase-2, which was 
considered as 100%. 
presence of cycloheximide (10 pg/ml) and cycloheximide- 
glucagon (10 pg/ml and M) in  hepatocytes using pulse- 
chase protocols. As shown in Fig. 5, cycloheximide in the 
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presence or absence of glucagon did not modify the half-life 
of PFK-2/FBPase-2 mRNA. 
DISCUSSION 
Glucagon induces a series of metabolic changes in  the liver 
that converts the hepatocyte into a net producer of  glucose. 
Glucagon exerts its action via the formation of cAMP and  the 
activation of CAMP-dependent protein kinase. PFK-2/ 
FBPase-2 is phosphorylated by CAMP-dependent protein ki- 
nase, and this phosphorylation results in  the activation of 
phosphatase and in the inactivation of kinase activities, caus- 
ing the disappearance of Fru-2,6-P2 from the liver  cell  (1-3). 
The results reported herein show that the decrease in  Fru- 
2,6-P2 concentration is also due, in  part, to a decrease in  the 
amount of bi~nctional enzyme. 
Glucagon rapidly down-regulated PFK-2FBPase-2 gene 
transcription and steady-state mRNA  levels (Table I and Fig. 
3). This  pattern of hormonal regulation is similar to  that of 
hepatic glycolysis regulatory enzymes and opposite to that of 
gluconeogenesis  (37). Thus, while  glucokinase and pyruvate 
kinase mRNA levels decreased in rat fiver after glucagon or 
cAMP administration, as a consequence of the decrease in 
their transcription rates (12,381, the  PEPCK mRNA content 
increased due to  the increase in its  transcription  rate (26-29, 
31) (Tabfe I and Fig. 3). This modulation indicates the coor- 
dinate hormonal regulation of gene expression of hepatic 
glycol~ic/gluconeogenic enzymes  (37,  39). cAMP prevented 
the increase in PFK-SfFBPase-2 mRNA induced by insulin 
or glucocorticoids in  rat hepatoma cells (10) and  in primary 
culture of hepatocytes (11). The decrease  in PFK-Z/FBPase- 
2 mRNA  levels in parallel to  the inhibition of the  transcrip- 
tion rate of the  PFK-2/FBPase gene  seems to indicate that 
glucagon regulates the PFK-2/FBPase-2 mRNA content in 
uivo at the transcriptional level. This inhibition of the  tran- 
scription rate could  explain the decrease observed in  the  PFK- 
2/FBPase-2 mRNA levels  in situations with high  glucagon/ 
insulin ratio, like after partial hepatectomy (9) or during 
diabetes (8). 
The ability of glucagon to decrease PFK-2/FBPase-2 gene 
transcription is probably mediated by a hormone response 
element. Recently, Lange et ai. (40) have identified a gluco- 
corticoid response element in  the  first  intron of the gene of 
skeletal muscle/liver PFK-2IFBPase-2, which may explain 
the regulation of gene expression of PFK-2/FBPase-2 by 
glucocorticoids (41, 42). No consensus sequence known for 
cAMP response elements has been identified in the PFK-2/ 
FBPase-2 gene. A similar situation could be applied to insulin. 
Although it is known that the insulin increases PFK-21 
FBPase-2 gene transcription, probably also via a hormone 
response element, no consensus sequence has been found (40). 
Further studies are necessary to identify these putative glu- 
cagon and insulin response elements. 
Little is  known about the mechanism of mRNA degrada- 
tion. Evidence suggests that  the 3’-polyadenosine {poly(A)) 
tail may be involved  in the regulation of the mRNA turnover. 
The elongation of poly(A) tails of certain mRNAs correlates 
with their stabilization (35). Poly(A) tail-binding proteins 
interact with the poly(A) tail preventing deadenylation and 
subsequent degradation of mRNAs in vitro (43). A repeated 
AUUUA sequence  in the  3”nontranslated region appears to 
be responsible  for the destabilization of some  mRNAs (44- 
46). RNA folding also seems to have a role in mRNA stability, 
since it has been  shown that a stem loop in  the 3‘ terminus 
of the mRNA stabilized mRNAs of the  transferrin receptor 
(47,48) and histone (49). Modification of the length of hepatic 
PFK-PIFBPase-2 mRNA has  not been  observed (7,9, 10,41, 
42) nor has an AUUUA sequence been found in its 3’- 
nontranslated region (7, 50), and no study of RNA folding 
has been reported. No alteration in the degradation rate of 
PFK-2IFBPase-2 mRNA was observed when rat hepatoma 
cells were treated with insulin (10).  Kummel and Pilkis (11) 
described that cAMP decreased the stimulatory effect of 
dexamethasone at early times and increased the PFK-2/ 
FBPase-2 mRNA content after long incubation periods in 
culture of rat hepatocytes, suggesting to these authors that 
cAMP couid affect PFK-B/FBPase-2 mRNA stability. It is 
apparent from the  data presented here that glucagon  down- 
regulated PFK-2/FBPase-2 mRNA (Fig. 3) not only at the 
level of gene transcription (Table I) but also decreasing its 
half-life (Fig. 5). A similar mRNA degradation rate in the 
presence of glucagon has been  previously reported for  gluco- 
kinase (38). In contrast to the rapid disappearance of PFK- 
2/FBPase-2 mRNA in the pulse-chase experiments, its ap- 
parent rate of decay after addition of the transcriptional 
inhibitor actinomycin D was  much  slower, raising the possi- 
bility that a short lived  RNA and/or protein may  be  involved 
in the rapid turnover process. A similar suggestion comes 
from other studies (38). 
In conclusion, the results reported herein show a regulation 
of PFK-Z/FBPase-Z gene expression by  glucagon at  both the 
transcriptional and posttranscriptional levels. 
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